Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 6/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | HRH2 | P25021 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4751897 | 0.87 | L3MBTL1 (0.47) | KMT2AMEN1SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL4282373 | 0.87 | L3MBTL1 (0.47) | KMT2AMEN1SMN1; SMN2ALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL4287144 | 0.86 | HPGD (0.47) | KMT2APOLBSMN1; SMN2KDM4EALDH1A1 | |
| Hydrochloric Acid SCHEMBL4285610 | 0.86 | L3MBTL1 (0.46) | KMT2AMEN1SMN1; SMN2ALDH1A1TSHR | |
| SCHEMBL3493396 | 0.86 | TEAD1 (0.46) | KMT2AMEN1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL13705348 | 0.85 | GRIN2B (0.44) | KMT2AMEN1RAB9APOLBSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL4293711 | 0.84 | PARP1 (0.45) | KMT2AMEN1RAB9ASMN1; SMN2KDM4E | |
| Hydrochloric Acid SCHEMBL4293709 | 0.84 | PARP1 (0.45) | KMT2AMEN1RAB9ASMN1; SMN2KDM4E | |
| SCHEMBL4282336 | 0.84 | KMT2A (0.46) | KMT2AMEN1RAB9AHRH3KDM4E | |
| Hydrochloric Acid SCHEMBL4284628 | 0.84 | L3MBTL1 (0.46) | HRH3SMN1; SMN2KDM4EALDH1A1HRH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090227560-A1 | Substituted imidazole compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-09-10 | — | — | US | disclosed |
| US-20090156612-A1 | Substituted imidazole compound and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-18 | — | — | US | disclosed |
| WO-2008139941-A1 | SUBSTITUTED IMIDAZOLE COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090156612-A1 | Substituted imidazole compound and use thereof | REN, ACE, AGT | KMT2A 1049/4885MEN1 1254/4885RAB9A 1247/4885 |
| US-20090227560-A1 | Substituted imidazole compound and use thereof | REN, ACE, AGT | KMT2A 1049/4885MEN1 1254/4885RAB9A 1247/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.